Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 01, 2023

SELL
$1.2 - $2.19 $600 - $1,095
-500 Reduced 10.42%
4,300 $0
Q4 2022

Feb 07, 2023

SELL
$1.63 - $3.52 $34,882 - $75,328
-21,400 Reduced 81.68%
4,800 $6,000
Q3 2022

Oct 25, 2022

SELL
$0.73 - $3.74 $1,898 - $9,724
-2,600 Reduced 9.03%
26,200 $42,000
Q2 2022

Aug 04, 2022

SELL
$2.2 - $4.2 $74,360 - $141,960
-33,800 Reduced 53.99%
28,800 $111,000
Q1 2022

Apr 14, 2022

SELL
$2.83 - $8.69 $378,654 - $1.16 Million
-133,800 Reduced 68.13%
62,600 $120,000
Q4 2021

Jan 18, 2022

BUY
$8.31 - $14.92 $789,450 - $1.42 Million
95,000 Added 93.69%
196,400 $387,000
Q3 2021

Oct 26, 2021

BUY
$9.15 - $13.28 $927,810 - $1.35 Million
101,400 New
101,400 $91,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $438M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.